Who Makes Tyrvaya Now? Harrow Owns the U.S. Brand

Harrow is now the company behind Tyrvaya in the United States. It completed its acquisition from Viatris on October 5, 2026, acquiring worldwide rights except in Japan. The FDA’s current Tyrvaya record lists the company as “HARROW EYE.” These details are current as of November 7, 2026. (Harrow closing announcement, FDA drug record)

Here, “makes” means the company that owns and markets the medicine—not necessarily the factory that physically produces it.

Why You May Still See Oyster Point or Viatris

Older product information carries different company names. The prescribing information revised in February 2024 says “Manufactured for: Oyster Point Pharma, Inc., a Viatris company.” That wording identifies the company the product was manufactured for; it does not name the physical manufacturing facility. (Tyrvaya prescribing information)

The key ownership dates are:

• August 6, 2026: Harrow announced an agreement to acquire Tyrvaya from Viatris. At that point, closing was still subject to conditions. (Acquisition agreement announcement)
• October 5, 2026: Harrow announced that the acquisition had closed. This is the completed ownership change, not just a plan to buy the brand. (Closing announcement)

So an older reference to Oyster Point or Viatris is not the current answer to who owns the U.S. brand. If you are checking the company information on a particular carton, a pharmacist can help reconcile it with the current product record.

The Japan Exception

Harrow did not acquire Tyrvaya’s commercialization rights in Japan. Viatris retained those rights and agreed to pay Harrow royalties on any future net sales there. “Harrow owns Tyrvaya globally” therefore needs that exception. (Harrow closing announcement)

What This Means for Your Prescription

Tyrvaya remains a prescription varenicline nasal spray for the signs and symptoms of dry eye disease, not an eye drop. (Official Tyrvaya patient site)

At closing, Harrow said prescriptions could be sent to its pharmacy partner, PhilRx, or to any retail pharmacy. For a refill, price or coverage question, ask your pharmacy to check the current arrangements rather than relying on an older savings offer. (Harrow closing announcement)

Use Tyrvaya exactly as your prescriber directs, and read the instructions supplied with each refill in case there is new information. (Tyrvaya patient information and instructions)